These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 7077464)

  • 21. Combating counterfeit drugs.
    Lancet; 2008 May; 371(9624):1551. PubMed ID: 18468523
    [No Abstract]   [Full Text] [Related]  

  • 22. Application of ISO 9002 and FDA's good manufacturing practices to general chemical manufacturing.
    Kauffman JM; Weiler ED
    Qual Assur; 1992 Jun; 1(3):213-6. PubMed ID: 1344676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parenteral manufacturing and legal regulations.
    Tamura LK
    Bull Parenter Drug Assoc; 1968; 22(6):261-6. PubMed ID: 5727161
    [No Abstract]   [Full Text] [Related]  

  • 24. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 25. Counterfeiting and piracy of pharmaceuticals.
    Grackin A
    IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
    [No Abstract]   [Full Text] [Related]  

  • 26. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL; Lynch MA
    J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802
    [No Abstract]   [Full Text] [Related]  

  • 27. As Genzyme flounders, competitors and activist investors swoop in.
    Allison M
    Nat Biotechnol; 2010 Jan; 28(1):3-4. PubMed ID: 20062016
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent developments in aluminium contamination of products used in parenteral nutrition.
    Gura KM; Puder M
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):239-46. PubMed ID: 16607123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manufacturing misdeeds cost Abbott record-breaking payment.
    Lewis C
    FDA Consum; 2000; 34(3):38-9. PubMed ID: 11521253
    [No Abstract]   [Full Text] [Related]  

  • 30. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 31. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 32. Business considerations in the development of probiotics.
    Hoffman FA
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S141-3; discussion S144-51. PubMed ID: 18181721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of plasma derivatives in the U.S.A.
    Finlayson JS
    Dev Biol Stand; 1993; 81():277-81. PubMed ID: 8174815
    [No Abstract]   [Full Text] [Related]  

  • 34. Validation--how much is required?
    Sharp J
    PDA J Pharm Sci Technol; 1995; 49(3):111-8. PubMed ID: 7613988
    [No Abstract]   [Full Text] [Related]  

  • 35. Personal responsibility and the Food and Drug Law.
    Janssen WF
    FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122
    [No Abstract]   [Full Text] [Related]  

  • 36. Botanical drugs: a future for herbal medicines.
    Li W
    J Contemp Health Law Policy; 2002; 19(1):117-49. PubMed ID: 12733224
    [No Abstract]   [Full Text] [Related]  

  • 37. Standardization of forensic drug analyses.
    Frank RS; Gunn JW
    J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386
    [No Abstract]   [Full Text] [Related]  

  • 38. Good validation practices: FDA issues.
    Levchuk JW
    PDA J Pharm Sci Technol; 1994; 48(5):221-3. PubMed ID: 8000894
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug development history, "overview," and what are GCPs?
    Heilman RD
    Qual Assur; 1995 Mar; 4(1):75-9. PubMed ID: 8520867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The drug industry and drug effectiveness.
    Curran WJ
    N Engl J Med; 1970 Aug; 283(6):304-5. PubMed ID: 5427059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.